Talis Biomedical Corp

NASDAQ:TLIS  
0.84
-0.01 (-0.92%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)45.55M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.7 Million
Adjusted EPS-$0.81
See more estimates
10-Day MA$0.89
50-Day MA$1.03
200-Day MA$3.19
See more pivots

Talis Biomedical Corp Stock, NASDAQ:TLIS

230 Constitution Drive, Menlo Park, California 94025
United States of America
Phone: +1.650.433.3000
Number of Employees: 262

Description

Talis Biomedical Corp. develops and commercialize innovative products that are designed to enable accurate, reliable, low cost and rapid molecular testing for infectious diseases. The company was founded on June 26, 2013 and is headquartered in Menlo Park, CA.